Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery vs surgery plus adjuvant capecitabine + cisplatin in curatively resected esophageal cancer
KCT0003636Phase 3Completed
- Sponsor
- Samsung Medical Center
- Start
- Mar 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine, cisplatin in esophageal cancer, sponsored by Samsung Medical Center. Started Mar 2005; status: completed.
02
Drugs
capecitabinecisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on KCT0003636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003636.